Pacira Pharmaceuticals Tops 4Q Earnings Expectations
Pacira (PCRX) reported mixed fourth quarter results.
Pacira Pharmaceuticals (PCRX) - Get Pacira Biosciences, Inc. Report was able to top analysts' fourth quarter bottom-line expectations, but missed on fourth quarter revenue.
The company reported earnings of 9 cents per share on revenue of $72.9 million. Analysts' on average were expecting the company to report earnings of 2 cents per share on revenue of $73.2 million.
Scroll to Continue
